These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 6088336)
1. [Combinations of antimycotics]. Viviani MA G Ital Chemioter; 1984; 31(1-2):1-6. PubMed ID: 6088336 [No Abstract] [Full Text] [Related]
2. [Principles of the treatment of organic and systemic mycoses]. Pawlik B; Laskownicka Z Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):727-31. PubMed ID: 2084628 [No Abstract] [Full Text] [Related]
3. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids. O'Day DM; Ray WA; Robinson R; Head WS Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389 [TBL] [Abstract][Full Text] [Related]
4. Strategies in the treatment of systemic fungal infections. Medoff G; Kobayashi GS N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703 [No Abstract] [Full Text] [Related]
5. A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Duggineni S; Srivastava G; Kundu B; Kumar M; Chaturvedi AK; Shukla PK Int J Antimicrob Agents; 2007 Jan; 29(1):73-8. PubMed ID: 17156978 [TBL] [Abstract][Full Text] [Related]
6. Drugs for treatments of systemic fungal infections. Med Lett Drugs Ther; 1982 Apr; 24(606):36-8. PubMed ID: 6281635 [No Abstract] [Full Text] [Related]
7. In vitro and in vivo studies on synergistic antifungal activity. Shadomy S Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191 [No Abstract] [Full Text] [Related]
8. Influence of the corneal epithelium on the efficacy of topical antifungal agents. O'Day DM; Ray WA; Head WS; Robinson RD Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):855-9. PubMed ID: 6329991 [TBL] [Abstract][Full Text] [Related]
9. [Antifungal agents in otorhinolaryngology]. Dupont B; Drouhet E Ann Otolaryngol Chir Cervicofac; 1982; 99(12):575-80. PubMed ID: 7158918 [TBL] [Abstract][Full Text] [Related]
10. [In-vitro and in-vivo activity of itraconazole]. Van Cutsem J Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204 [TBL] [Abstract][Full Text] [Related]
11. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp. Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870 [TBL] [Abstract][Full Text] [Related]
12. [The activity of systemic antimycotic drug combinations]. Viudes A; Pemán J; Cantón E; López-Ribot J; Gobernado M Rev Esp Quimioter; 2001 Mar; 14(1):30-9. PubMed ID: 11376347 [TBL] [Abstract][Full Text] [Related]
13. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole. Wei GX; Bobek LA J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161 [TBL] [Abstract][Full Text] [Related]
15. Amphotericin B. Old drug, new therapy.?2110. Medoff G; Kobayashi GS JAMA; 1975 May; 232(6):619-20. PubMed ID: 1091753 [No Abstract] [Full Text] [Related]
16. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine. Strippoli V; Torosantucci A; Simonetti N Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120 [TBL] [Abstract][Full Text] [Related]
17. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Odds FC Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266 [TBL] [Abstract][Full Text] [Related]
19. [Endophytic fungi from Ginkgo biloba and their biological activities]. Yu H; Zhang L; Li L; Li W; Han T; Guo L; Qin L Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2133-7. PubMed ID: 21046747 [TBL] [Abstract][Full Text] [Related]
20. Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents. Meunier F Eur J Clin Microbiol; 1986 Feb; 5(1):103-9. PubMed ID: 3516681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]